Article
Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Hematology/oncology clinics of North America - 1 Jun 2020
Sapienza Maria Rosaria, Pileri Stefano
Abstract excerpt
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic neoplasm with a dismal prognosis and no standard therapy. In the past, its cellular ontogenesis was obscure, and BPDCN had been erroneously named CD56+/TdT+ blastic NK cell tumor and CD4+/CD56+ hematodermic neoplasm. Finally, in 2008, the BPDCN was correctly recognized as a neoplasm deriving from the malignant transformation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
